E. Scheibel
- Hematology top 1%
- Hemophilia Treatment and Research 21
- Platelet Disorders and Treatments 10
- Blood Coagulation and Thrombosis Mechanisms 8
- Chronic Myeloid Leukemia Treatments 4
- Virology top 5%
- HIV Research and Treatment 6
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Infectious Diseases top 10%
- Periodontics top 10%
-
- Cancer-related gene regulation 6
-
- Childhood Cancer Survivors' Quality of Life 5
- Co-authors
- Amy D. ShapiroRalph A. GruppoG C WhiteMarilyn J. Manco‐JohnsonGomperts EdS CourterLee MGordon Em
- Cited by
- HematologyVirologyGenetics
- Partner nations
- DenmarkSwedenUnited States
In The Last Decade
E. Scheibel
42 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Hematology 896
- Virology 142
- Genetics 211
- Infectious Diseases 162
- Periodontics 21
Countries citing papers authored by E. Scheibel
This map shows the geographic impact of E. Scheibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Scheibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Scheibel more than expected).
Fields of papers citing papers by E. Scheibel
This network shows the impact of papers produced by E. Scheibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Scheibel. The network helps show where E. Scheibel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Scheibel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 72 | |
| 2 | 2003 | 10 | |
| 3 | 2000 | 58 | |
| 4 | 2000 | 36 | |
| 5 | 1999 | 5 | |
| 6 | 1998 | 22 | |
| 7 | 1997 | 3 | |
| 8 | 1996 | 109 | |
| 9 | 1995 | 8 | |
| 10 | Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols. | 1994 | 38 |
| 11 | 1994 | 126 | |
| 12 | 1992 | 1 | |
| 13 | 1992 | 18 | |
| 14 | 1992 | 10 | |
| 15 | 1989 | 125 | |
| 16 | 1989 | 3 | |
| 17 | 1989 | 73 | |
| 18 | 1988 | 5 | |
| 19 | [Cancer in childhood in Denmark 1943-1980. Cancer statistics No. 11]. | 1984 | 3 |
| 20 | The influence of apnea and physical activity on arterial blood pressure and transcutaneous oxygen tension in the newborn. | 1979 | 1 |
About E. Scheibel
E. Scheibel is a scholar working on Hematology, Virology and Genetics, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (10 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers), HIV Research and Treatment (6 papers), Cancer-related gene regulation (6 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (896 citations), Virology (142 citations) and Genetics (211 citations). E. Scheibel has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Amy D. Shapiro, Ralph A. Gruppo, G C White, Marilyn J. Manco‐Johnson, Gomperts Ed, S Courter, Lee M, Gordon Em, J. Ingerslev and H Hertz. Their work appears in journals such as Acta Paediatrica, Haemophilia, Thrombosis and Haemostasis, British Journal of Haematology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.